:quality(70)/cloudfront-eu-central-1.images.arcpublishing.com/prisaradio/6QF7ZFKHNNL7HOSGUAPXZNOTBM.jpg)
Científicos de Oxford demuestran la eficacia de un análisis de sangre que detecta 50 tipos de cáncer
Un análisis de sangre que detecta más de 50 tipos de cáncer ha demostrado su eficacia en el mayor ensayo clínico, en el que han participado 5.000 personas y que se ha realizado en una decena de hospitales públicos del Reino Unido: ha acertado en el 75% de los casos y, de ellos, en el 85%, incluso, ha logrado identificar el lugar del cuerpo humano dónde está situado el tumor
02/06/2023 - 11:54
Javier Gregori
:quality(70)/cloudfront-eu-central-1.images.arcpublishing.com/prisaradio/NWAAXLDR65FC7BTXVOTY5ILBSE.jpg)
:quality(70)/cloudfront-eu-central-1.images.arcpublishing.com/prisaradio/26SXNDAMOFHSHB4CJW5CTMHN5A.jpg)
:quality(70)/cloudfront-eu-central-1.images.arcpublishing.com/prisaradio/4Z3KKN5FHVDRFJSSKJ4KWMAFBM.jpeg)
:quality(70)/cloudfront-eu-central-1.images.arcpublishing.com/prisaradio/2I7DZNKBRFDVHOHQWFKJOTNK6Q.jpg)
:quality(70):focal(626x278:636x288)/cloudfront-eu-central-1.images.arcpublishing.com/prisaradio/WF2NS24VIRG7FPLSNFLNBVRPH4.png)
:quality(70):focal(1070x830:1080x840)/cloudfront-eu-central-1.images.arcpublishing.com/prisaradio/DNB5XSWO3BAONOFPVCC63NSXFE.jpg)
:quality(70)/cloudfront-eu-central-1.images.arcpublishing.com/prisaradio/R6M53I5SJBAT5AMO6XVXCZKCYE.png)
:quality(70)/cloudfront-eu-central-1.images.arcpublishing.com/prisaradio/OUW3YQTQ3NFXJEIBA47LPL5JHM.jpeg)
:quality(70)/cloudfront-eu-central-1.images.arcpublishing.com/prisaradio/IBUFAOGE4BGDLIO6DKAQ64J2PM.png)
:quality(70)/cloudfront-eu-central-1.images.arcpublishing.com/prisaradio/FKJJVGCHYREE5JTLFLORQOA74U.jpg)
:quality(70)/cloudfront-eu-central-1.images.arcpublishing.com/prisaradio/M2FOFBIHRFCB5NPNRZSP6C6PRE.jpg)
:quality(70)/cloudfront-eu-central-1.images.arcpublishing.com/prisaradio/SL5XPQQVTNAE7LFSBIM56R4HPM.png)
:quality(70)/cloudfront-eu-central-1.images.arcpublishing.com/prisaradio/PVLBUAJGIVE2HB326IDVQNBYBQ.jpg)
:quality(70):focal(3495x2145:3505x2155)/cloudfront-eu-central-1.images.arcpublishing.com/prisaradio/D6OUOAZNLZDLNBCZOWXRYKISTA.jpg)
:quality(70)/cloudfront-eu-central-1.images.arcpublishing.com/prisaradio/FIOUNBZIWFEUDLB7IGIARQOEIA.jpg)
:quality(70)/cloudfront-eu-central-1.images.arcpublishing.com/prisaradio/5V2EYHN4YVAALB7GTAJAGXXTOM.jpg)
:quality(70)/cloudfront-eu-central-1.images.arcpublishing.com/prisaradio/NMRWJGMFVVFO3PL3PNN7C3KT4E.jpg)
:quality(70)/cloudfront-eu-central-1.images.arcpublishing.com/prisaradio/NPO3O4E4XBAWXH3TPHAKZP7GMA.jpeg)
:quality(70)/cloudfront-eu-central-1.images.arcpublishing.com/prisaradio/VBB5Z57BJ5BMNKF2G4IGJXZU3I.jpg)
:quality(70)/cloudfront-eu-central-1.images.arcpublishing.com/prisaradio/CL6PSYHZLJG5NEVDG7HIAAKMJQ.png)
:quality(70)/cloudfront-eu-central-1.images.arcpublishing.com/prisaradio/2IB32IEUNZE25JYNCGVE6KLYWY.png)
:quality(70)/cloudfront-eu-central-1.images.arcpublishing.com/prisaradio/5MONTHDSBVODHOK4MEEE53RGK4.jpg)
:quality(70)/cloudfront-eu-central-1.images.arcpublishing.com/prisaradio/GCHLHUIIOJE3ZI34UHFFFWW5Z4.jpg)
:quality(70):focal(696x270:706x280)/cloudfront-eu-central-1.images.arcpublishing.com/prisaradio/NNOV6WYOZBHHTEJVRU2HTNGAX4.jpg)
